サマリー

市場の分析と洞察。血漿分画の世界市場
2020年の血漿分画の世界市場規模は26384百万米ドルで、2027年末には44034百万米ドルに達すると予測され、2021年から2027年の間に7.63%のCAGRで推移するものと思われます。
血漿分画の世界市場範囲と市場規模
血漿分画の世界市場は、地域（国）別、企業別、タイプ別、用途別に分類されています。血漿分画の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるようになることでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別の売上、収益、2016-2027年までの予測に焦点を当てています。

会社別
武田薬品工業
CSL
グリフォルス
オクタファーマ
ケドリオン
LFBグループ
ビオテスト
BPL
RAAS
CBPO
花蘭咲バイオ
天壇バイオ
双林董事長
ボヤ・バイオ
遠大周陽
ウェイグァン バイオ
南越バイオ
KMバイオロジクス
種類別セグメント
アルブミン
免疫グロブリン
凝固因子
その他
用途別セグメント
病院
小売店
その他
地域別
北米
米国
カナダ
メキシコ
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
東南アジア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
南米
ブラジル
中近東・アフリカ
中東
アフリカ

ページTOPに戻る

目次

1 BLOOD PLASMA FRACTIONATION MARKET OVERVIEW 1
1.1 Blood Plasma Fractionation Product Overview 1
1.2 Blood Plasma Fractionation Market Segment by Type 4
1.2.1 Albumin 4
1.2.2 Immune Globulin 5
1.2.3 Coagulation Factor 6
1.3 Global Blood Plasma Fractionation Market Size by Type 7
1.3.1 Global Blood Plasma Fractionation Market Size Overview by Type (2016-2027) 8
1.3.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2016-2021) 9
1.3.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Type (2016-2021) 9
1.3.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Type (2016-2021) 10
1.3.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2016-2021) 11
1.3.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2022-2027) 12
1.3.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Type (2022-2027) 12
1.3.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Type (2022-2027) 13
1.3.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2022-2027) 14
1.4 Key Regions Market Size Segment by Type 15
1.4.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 15
1.4.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 16
1.4.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 18
1.4.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 20
1.4.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 21
2 BLOOD PLASMA FRACTIONATION MARKET COMPETITION BY COMPANY 24
2.1 Global Top Players by Blood Plasma Fractionation Sales (2019-2021) 24
2.2 Global Top Players by Blood Plasma Fractionation Revenue (2019-2021) 25
2.3 Global Top Players by Blood Plasma Fractionation Price (2019-2021) 27
2.4 Global Top Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type 28
2.5 Blood Plasma Fractionation Market Competitive Situation and Trends 28
2.5.1 Blood Plasma Fractionation Market Concentration Rate (2019-2021) 28
2.5.2 Global 5 Largest Manufacturers by Blood Plasma Fractionation Sales and Revenue in 2020 29
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020) 30
2.7 Founded Date of Key Blood Plasma Fractionation Manufacturers 31
2.8 Key Manufacturers Blood Plasma Fractionation Product Offered 31
2.9 Mergers & Acquisitions, Expansion 32
3 BLOOD PLASMA FRACTIONATION STATUS AND OUTLOOK BY REGION 35
3.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2016 VS 2021 VS 2026 35
3.2 Global Blood Plasma Fractionation Historic Market Size by Region 35
3.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 35
3.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2016-2021) 36
3.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2016-2021) 37
3.3 Global Blood Plasma Fractionation Forecasted Market Size by Region 37
3.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 37
3.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2022-2027) 38
3.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2022-2027) 38
4 BLOOD PLASMA FRACTIONATION BY APPLICATION 39
4.1 Blood Plasma Fractionation Market Segment by Application 39
4.1.1 Hospital 39
4.1.2 Retail Pharmacy 40
4.2 Global Blood Plasma Fractionation Market Size by Application 41
4.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2016-2027) 42
4.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2016-2021) 43
4.2.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Application (2016-2021) 43
4.2.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Application (2016-2021) 44
4.2.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2016-2021) 45
4.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2022-2027) 46
4.2.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Application (2022-2027) 46
4.2.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Application (2022-2027) 47
4.2.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2022-2027) 48
4.3 Key Regions Market Size Segment by Application 49
4.3.1 North America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 49
4.3.2 Europe Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 50
4.3.3 Asia-Pacific Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 51
4.3.4 South America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 51
4.3.5 Middle East and Africa Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 52
5 NORTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 54
5.1 North America Blood Plasma Fractionation Historic Market Size by Country 54
5.1.1 North America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 54
5.1.2 North America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 54
5.2 North America Blood Plasma Fractionation Forecasted Market Size by Country 55
5.2.1 North America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 55
5.2.2 North America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 56
6 EUROPE BLOOD PLASMA FRACTIONATION BY COUNTRY 57
6.1 Europe Blood Plasma Fractionation Historic Market Size by Country 57
6.1.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 57
6.1.2 Europe Blood Plasma Fractionation Sales in Value by Country (2016-2021) 57
6.2 Europe Blood Plasma Fractionation Forecasted Market Size by Country 58
6.2.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 58
6.2.2 Europe Blood Plasma Fractionation Sales in Value by Country (2022-2027) 59
7 ASIA-PACIFIC BLOOD PLASMA FRACTIONATION BY REGION 60
7.1 Asia-Pacific Blood Plasma Fractionation Historic Market Size by Region 60
7.1.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 60
7.1.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2016-2021) 61
7.2 Asia-Pacific Blood Plasma Fractionation Forecasted Market Size by Region 62
7.2.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 62
7.2.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2022-2027) 63
8 SOUTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 64
8.1 South America Blood Plasma Fractionation Historic Market Size by Country 64
8.1.1 South America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 64
8.1.2 South America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 64
8.2 South America Blood Plasma Fractionation Forecasted Market Size by Country 65
8.2.1 South America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 65
8.2.2 South America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 66
9 MIDDLE EAST AND AFRICA BLOOD PLASMA FRACTIONATION BY COUNTRY 67
9.1 Middle East and Africa Blood Plasma Fractionation Historic Market Size by Country 67
9.1.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 67
9.1.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2016-2021) 67
9.2 Middle East and Africa Blood Plasma Fractionation Forecasted Market Size by Country 68
9.2.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 68
9.2.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2022-2027) 69
10 COMPANY PROFILES AND KEY FIGURES IN BLOOD PLASMA FRACTIONATION BUSINESS 70
10.1 Takeda 70
10.1.1 Takeda Company Information 70
10.1.2 Takeda Blood Plasma Fractionation Product Offered 71
10.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 72
10.1.4 Takeda Main Business Overview 72
10.1.5 Takeda Latest Developments 72
10.2 CSL 74
10.2.1 CSL Company Information 74
10.2.2 CSL Blood Plasma Fractionation Product Offered 75
10.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 76
10.2.4 CSL Main Business Overview 76
10.2.5 CSL Latest Developments 76
10.3 Grifols 77
10.3.1 Grifols Company Information 77
10.3.2 Grifols Blood Plasma Fractionation Product Offered 78
10.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 80
10.3.4 Grifols Main Business Overview 80
10.3.5 Grifols Latest Developments 80
10.4 Octapharma 81
10.4.1 Octapharma Company Information 81
10.4.2 Octapharma Blood Plasma Fractionation Product Offered 82
10.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 83
10.4.4 Octapharma Main Business Overview 83
10.4.5 Octapharma Latest Developments 83
10.5 Kedrion 84
10.5.1 Kedrion Company Information 84
10.5.2 Kedrion Blood Plasma Fractionation Product Offered 84
10.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 85
10.5.4 Kedrion Main Business Overview 86
10.6 LFB Group 86
10.6.1 LFB Group Company Information 86
10.6.2 LFB Group Blood Plasma Fractionation Product Offered 87
10.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 87
10.6.4 LFB Group Main Business Overview 87
10.7 Biotest 88
10.7.1 Biotest Company Information 88
10.7.2 Biotest Blood Plasma Fractionation Product Offered 89
10.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 89
10.7.4 Biotest Main Business Overview 89
10.8 BPL 90
10.8.1 BPL Company Information 90
10.8.2 BPL Blood Plasma Fractionation Product Offered 90
10.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 91
10.8.4 BPL Main Business Overview 91
10.8.5 BPL Latest Developments 92
10.9 RAAS 93
10.9.1 RAAS Company Information 93
10.9.2 RAAS Blood Plasma Fractionation Product Offered 93
10.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 95
10.9.4 RAAS Main Business Overview 95
10.9.5 RAAS Latest Developments 96
10.10 CBPO 97
10.10.1 CBPO Company Information 97
10.10.2 CBPO Blood Plasma Fractionation Product Offered 98
10.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 98
10.10.4 CBPO Main Business Overview 98
10.10.5 CBPO Latest Developments 98
10.11 Hualan Bio 100
10.11.1 Hualan Bio Company Information 100
10.11.2 Hualan Bio Blood Plasma Fractionation Product Offered 100
10.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 102
10.11.4 Hualan Bio Main Business Overview 102
10.12 Tiantan Bio 103
10.12.1 Tiantan Bio Corporation Information 103
10.12.2 Tiantan Bio Blood Plasma Fractionation Products Offered 104
10.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 104
10.12.4 Tiantan Bio Main Business Overview 105
10.13 Shuanglin Bio 105
10.13.1 Shuanglin Bio Corporation Information 105
10.13.2 Shuanglin Bio Blood Plasma Fractionation Products Offered 106
10.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 106
10.13.4 Shuanglin Bio Main Business Overview 107
10.14 Boya Bio 107
10.14.1 Boya Bio Corporation Information 107
10.14.2 Boya Bio Blood Plasma Fractionation Products Offered 108
10.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 109
10.14.4 Boya Bio Main Business Overview 109
10.15 Yuanda Shuyang 110
10.15.1 Yuanda Shuyang Corporation Information 110
10.15.2 Yuanda Shuyang Blood Plasma Fractionation Products Offered 110
10.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 111
10.15.4 Yuanda Shuyang Main Business Overview 112
10.16 Weiguang Bio 112
10.16.1 Weiguang Bio Corporation Information 112
10.16.2 Weiguang Bio Blood Plasma Fractionation Products Offered 113
10.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 114
10.16.4 Weiguang Bio Main Business Overview 114
10.17 Nanyue Bio 115
10.17.1 Nanyue Bio Corporation Information 115
10.17.2 Nanyue Bio Blood Plasma Fractionation Products Offered 115
10.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 116
10.17.4 Nanyue Bio Main Business Overview 117
10.18 KM Biologics 117
10.18.1 KM Biologics Corporation Information 117
10.18.2 KM Biologics Blood Plasma Fractionation Products Offered 118
10.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 120
10.18.4 KM Biologics Main Business Overview 121
10.18.5 KM Biologics Recent Development 121
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 123
11.1 Blood Plasma Fractionation Key Raw Materials 123
11.1.1 Key Raw Materials 123
11.1.2 Raw Materials Key Suppliers 125
11.2 Manufacturing Cost Structure 126
11.2.1 Raw Materials 126
11.2.2 Labor Cost 126
11.2.3 Manufacturing Expenses 127
11.3 Manufacturing Process Analysis of Blood Plasma Fractionation 127
11.4 Blood Plasma Fractionation Industrial Chain Analysis 129
11.5 Blood Plasma Fractionation Market Dynamics 130
11.5.1 Industry Trends 130
11.5.2 Market Drivers 131
11.5.3 Market Challenges 132
11.5.4 Market Restraints 132
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 133
12.1 Sales Channel 133
12.2 Blood Plasma Fractionation Distributors 134
12.3 Blood Plasma Fractionation Downstream Customers 137
13 RESEARCH FINDINGS AND CONCLUSION 140
14 APPENDIX 142
14.1 Research Methodology 142
14.1.1 Methodology/Research Approach 142
14.1.1.1 Research Programs/Design 142
14.1.1.2 Market Size Estimation 143
14.1.1.3 Market Breakdown and Data Triangulation 144
14.1.2 Data Source 145
14.1.2.1 Secondary Sources 145
14.1.2.2 Primary Sources 146
14.2 Author Details 148
14.3 Disclaimer 149